Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000711377-17-000031)

Filing Details

Accession Number:: 0000711377-17-000031
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-10-06 17:14:21
Reporting Period:: 2017-10-06

Accepted Time:: 2017-10-06 17:14:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
711377	Neogen Corp	NEOG	In Vitro & In Vivo Diagnostic Substances (2835)	382367843

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1168789	L James Herbert	Neogen Corp 620 Lesher Place Lansing MI 48912	Executive Chairman	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-10-04	14,513	$28.67	883,725	No	4	M	Direct
Common Stock	Acquisiton	2017-10-04	2,218	$28.67	885,943	No	4	M	Direct
Common Stock	Disposition	2017-10-04	14,513	$78.32	871,430	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock (Right to Buy)	Disposition	2012-10-04	18,000	$0.00	18,000	$28.67

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
254,425		2017-10-04	No	4	M	Direct

Footnotes

Options were granted on 10/4/2012, have five year lives, and vest in equal annual 20% installments on the first five anniversary dates of the grant
The option plan provides for the exchange of outstanding options for shares in an amount equal to the employee's equity in the options held